Compare GFL & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GFL | HOLX |
|---|---|---|
| Founded | 2007 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Electronics |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0B | 16.9B |
| IPO Year | 2019 | 1995 |
| Metric | GFL | HOLX |
|---|---|---|
| Price | $40.32 | $76.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 13 |
| Target Price | $55.22 | ★ $77.89 |
| AVG Volume (30 Days) | 2.7M | ★ 25.5M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.16% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | ★ $4,100,500,000.00 |
| Revenue This Year | $8.18 | $4.74 |
| Revenue Next Year | $7.20 | $5.03 |
| P/E Ratio | ★ $5.95 | $96.23 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $36.96 | $51.90 |
| 52 Week High | $52.00 | $76.07 |
| Indicator | GFL | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 69.09 |
| Support Level | $38.60 | $75.10 |
| Resistance Level | $45.68 | N/A |
| Average True Range (ATR) | 1.48 | 0.19 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 44.77 | 95.19 |
GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.